57 related articles for article (PubMed ID: 29616847)
21. Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.
Rhee JY; Tremblay D; Chan AM; Tallman MS; Mascarenhas J
Blood Adv; 2019 Jun; 3(12):1854-1857. PubMed ID: 31213431
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of acute promyelocytic leukemia in pregnancy with single-agent all-trans retinoic acid.
Nellessen CM; Janzen V; Mayer K; Giovannini G; Gembruch U; Brossart P; Merz WM
Arch Gynecol Obstet; 2018 Feb; 297(2):281-284. PubMed ID: 29110117
[TBL] [Abstract][Full Text] [Related]
23. Effect of Therapeutically Related Drugs on Coagulation-Anticoagulation Balance in Acute Promyelocytic Leukemia.
Xiao M; Zhou P; Sun K
Clin Appl Thromb Hemost; 2022; 28():10760296221080166. PubMed ID: 35187963
[TBL] [Abstract][Full Text] [Related]
24. Curative strategies in APL.
Iland HJ
Semin Hematol; 2019 Apr; 56(2):131-138. PubMed ID: 30926089
[TBL] [Abstract][Full Text] [Related]
25. Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?
Tsimberidou AM; Kantarjian H; Keating MJ; Estey E
Leuk Lymphoma; 2006 Nov; 47(11):2282-8. PubMed ID: 17107899
[TBL] [Abstract][Full Text] [Related]
26. Differentiation syndrome in acute promyelocytic leukaemia.
Stahl M; Tallman MS
Br J Haematol; 2019 Oct; 187(2):157-162. PubMed ID: 31410848
[TBL] [Abstract][Full Text] [Related]
27. All trans retinoic acid treatment for patients with acute promyelocytic leukemia.
Fenaux P; Castaigne S; Chomienne C; Dombret H; Degos L
Leukemia; 1992; 6 Suppl 1():64-6. PubMed ID: 1548938
[No Abstract] [Full Text] [Related]
28. The simpler, the better: oral arsenic for acute promyelocytic leukemia.
Zhu HH; Hu J; Lo-Coco F; Jin J
Blood; 2019 Aug; 134(7):597-605. PubMed ID: 31113776
[TBL] [Abstract][Full Text] [Related]
29. Differentiation therapy revisited.
de Thé H
Nat Rev Cancer; 2018 Feb; 18(2):117-127. PubMed ID: 29192213
[TBL] [Abstract][Full Text] [Related]
30. CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.
Burry LD; Seki JT
Ann Pharmacother; 2002 Dec; 36(12):1900-6. PubMed ID: 12452754
[TBL] [Abstract][Full Text] [Related]
31. Arsenic trioxide as a novel anti-glioma drug: a review.
Fang Y; Zhang Z
Cell Mol Biol Lett; 2020; 25():44. PubMed ID: 32983240
[TBL] [Abstract][Full Text] [Related]
32. Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.
Iland HJ; Wei A; Seymour JF
Best Pract Res Clin Haematol; 2014 Mar; 27(1):39-52. PubMed ID: 24907016
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia.
Soignet SL
Oncologist; 2001; 6 Suppl 2():11-6. PubMed ID: 11331435
[TBL] [Abstract][Full Text] [Related]
34. Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide.
Slack JL; Waxman S; Tricot G; Tallman MS; Bloomfield CD
Oncologist; 2002; 7 Suppl 1():1-13. PubMed ID: 11961204
[TBL] [Abstract][Full Text] [Related]
35. [Arsenic efficient in acute promyelocytic leukemia].
Lehmann S; Paul C
Lakartidningen; 1999 Dec; 96(50):5626-8. PubMed ID: 10643228
[TBL] [Abstract][Full Text] [Related]
36. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
Haanen C; Vermes I
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1738-41. PubMed ID: 10494320
[TBL] [Abstract][Full Text] [Related]
37. 2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Asou N
Intern Med; 2007; 46(2):91-3. PubMed ID: 17220606
[No Abstract] [Full Text] [Related]
38. Acute promyelocytic leukaemia in the all trans retinoic acid era.
DeLoughery TG; Goodnight SH
Med Oncol; 1996 Dec; 13(4):233-40. PubMed ID: 9152974
[TBL] [Abstract][Full Text] [Related]
39. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
Tallman MS
Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
[TBL] [Abstract][Full Text] [Related]
40. The use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia.
Zhang P
J Biol Regul Homeost Agents; 1999; 13(4):195-200. PubMed ID: 10703942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]